Leslie Bottorff
Senior Executive Advisor | Independent Board Member
San Francisco Bay Area
Overview
Work Experience
Principal
2020 - Current
Sr. Managing Director, Healthcare Investments
2018 - 2019
Led healthcare investing practice for corporate venture capital investing arm of GE. After a GE corporate restructuring, I led the healthcare investing team to market the GE Ventures healthcare portfolio, and ultimately consummate a successful sale to a prominent secondary investor, providing continued follow-on capital for the portfolio companies, and liquidity for GE.
Managing Director, Healthcare
2014 - 2018
Invested venture capital in innovative healthcare companies with strong growth prospects for the GE corporate venture platform. Sourced deals, led financing rounds, advised management teams as board member/observer, mentored investing team, provided strategic consultation on innovation and collaboration with start-up companies to GE Healthcare (operating business unit) executives globally. Areas of investment included digital therapeutics and diagnostics, mobile health, AI imaging.
Board of Directors
2006 - 2013
Start-up company developing a minimally invasive procedure to reduce spine pain for patients with degenerative disc disease. I led the Series A funding round, recruited management team as growth phases needed new talent.
Relievant Medsystems is a medical device company specializing in diagnosing and treating chronic low back pain.
Raised $273,550,000.00 from Vensana Capital, Morgenthaler Ventures, Endeavour Vision, Lightstone Ventures, Canaan Partners, New Enterprise Associates and Ally Bridge Group.
Board of Directors
2003 - 2013
Growth stage company marketing non-invasive neurostimulation for chronic treatment resistant depression. I co-led Series A funding round, and recruitment of initial management team. In 2015, I led the mezzanine round for GE Ventures and became Board Observer, followed by successful IPO in 3 years.
Managing Director
1998 - 2013
Venture capital firm focused on early stage technology investing.
ONSET Ventures provides early-stage venture capital in the areas of IT and medical.
Board of Directors
2003 - 2011
Start-up company developing transcatheter aortic valve (TAVI) devices for patients with aortic stenosis. Company acquired by Boston Scientific 2011.
Board of Directors
1998 - 2003
Start up company marketing device for spine surgery. Acquired By Abbott Labs 2003.
VP Marketing
1999 - 2000
Start-up company developing vascular filter devices to protect patients from embolic complications during interventional vascular procedures. Consultant initial VP Marketing during seed development. Acquired by Boston Scientific 2001.
VP Sales and Marketing, Medtronic CardioRhythm
1994 - 1998
Division of a major medical device company marketing cardiac ablation catheters and other electrophysiology products. CardioRhythm was a former start-up acquired by Medtronic pre-revenue, I was recruited to run commercial launch. Division was merged into Medtronic CRM division after break even was achieved.
Medtronic is a healthcare technology company that designs and develops AI-based products and solutions for the medical industry.
Raised $9,105,978,217.00 from NHS England.
Marketing Manager
1992 - 1994
Newly public company launching implantable cardioverter defibrillator devices (ICDs) for patients at risk for ventricular tachycardia or fibrillation.